| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/17/1993 | CN1069027A Aminocarboxylate ligands having substituted aromatic amide moieties |
| 02/16/1993 | US5187209 Storage stable protective colloids for use in medical diagnosis and/or therapy or as solid catalysts |
| 02/16/1993 | US5187077 Leukaemia inhibitory factor |
| 02/16/1993 | US5186924 Magnetic resonance human medical and veterinary imaging method |
| 02/16/1993 | US5186923 Enhancement of cellular accumulation of lipophilic cationic organometallic compounds by reduction of intramembrane potential |
| 02/16/1993 | US5186922 Injecting microspheres carrying nontoxic slow-dissolving radiation contrast agent into blood, radiation exposure, detection of defects |
| 02/16/1993 | CA1313617C Compositions for therapeutic percutaneous embolization and the use thereof |
| 02/10/1993 | EP0526503A1 Polymers as contrast media for magnetic resonance imaging. |
| 02/10/1993 | EP0403524B1 Preparation of nitruro compounds usable as radio-pharmaceutical products |
| 02/09/1993 | US5185368 Complex with trivalent metal ions; medical diagnosis and therapy |
| 02/04/1993 | WO1993002192A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | WO1993002105A1 Trifunctional compounds having specificity for multi-drug resistant cells |
| 02/04/1993 | WO1993001840A1 Synthesis of ioversol using chloroacetyl chloride |
| 02/04/1993 | WO1993001813A1 Platelet activating factor antagonists |
| 02/04/1993 | WO1992019213A3 Enhancement of abnormal tissue uptake of antibodies, tumor-specific agents or conjugates thereof for diagnostic imaging or therapy |
| 02/04/1993 | DE4125272A1 Glidant contg. X=ray contrast agent - useful in facilitating and controlling catheter |
| 02/04/1993 | CA2113578A1 Trifunctional compounds having specificity for multi-drug resistant cells |
| 02/04/1993 | CA2113206A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | CA2112562A1 Platelet activating factor antagonists |
| 02/04/1993 | CA2112486A1 Synthesis of ioversol using chloroacetyl chloride |
| 02/03/1993 | EP0525199A1 Composition containing ultrafine particles of magnetic metal oxide |
| 02/03/1993 | EP0525181A1 Novel lanthanide chelate-conjugated oligonucleotides. |
| 02/03/1993 | EP0525158A1 Hyperglycemic compositions |
| 02/03/1993 | EP0525149A1 Amylin activity assays. |
| 02/03/1993 | EP0524984A1 Lipophilic contrast agents for diagnostic image analysis |
| 02/03/1993 | EP0517740A4 Low molecular weight carbohydrates as additives to stabilize metal oxide compositions |
| 02/02/1993 | US5183654 Nonionic x-ray contrast medium with high iodine content |
| 02/02/1993 | CA2074867A1 Aminocarboxylate ligands having substituted aromatic amide moieties |
| 01/27/1993 | EP0524265A1 Contrast medium, process for its preparation and application to imagery |
| 01/27/1993 | EP0524239A1 Insoluble salts of lanthanides for the visual display, using nuclear magnetic resonance, of the gastro-intestinal tract. |
| 01/26/1993 | US5182081 Product to be used in occlusive epicutaneous testing for the purpose of demonstrating contact allergy to formaldehyde |
| 01/23/1993 | WO1993001837A1 Conjugated moieties for chelating paramagnetic metals |
| 01/21/1993 | WO1993001272A2 Bioassay method |
| 01/21/1993 | WO1993000933A1 Ultrasmall non-aggregated porous particles entrapping gas-bubbles |
| 01/21/1993 | WO1993000931A1 Novel compositions for magnetic resonance imaging |
| 01/21/1993 | WO1993000930A1 Improvements in or relating to contrast agents |
| 01/21/1993 | CA2112905A1 Ultrasmall non-aggregated porous particles entrapping gas-bubbles |
| 01/21/1993 | CA2112897A1 Bioassay method |
| 01/21/1993 | CA2112109A1 Improvements in or relating to contrast agents |
| 01/21/1993 | CA2110815A1 Novel compositions for magnetic resonance imaging |
| 01/20/1993 | EP0523572A1 Nuclear magnetic resonance imaging agent |
| 01/19/1993 | US5180820 Nucleic acid sequence code |
| 01/19/1993 | US5179955 Method of abdominal ultrasound imaging |
| 01/19/1993 | CA1312867C Manganese(ii) chelate contrast agents and methods |
| 01/13/1993 | EP0522007A1 A fonctionalized complexand |
| 01/13/1993 | EP0521880A1 Contrast media. |
| 01/12/1993 | US5179120 Porphycene compounds for photodynamic therapy |
| 01/12/1993 | US5179018 Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria |
| 01/11/1993 | WO1993000881A1 Treatment of hair loss and dermatological problems |
| 01/07/1993 | WO1993000101A1 Nanoparticles based on a polyoxyethylene and polylactic acid block copolymer |
| 01/07/1993 | WO1993000087A1 Porphycene compounds for photodynamic therapy |
| 01/07/1993 | EP0200750B1 Diester-dtpa-paramagnetic contrast agents for mri imaging, apparatus and methods |
| 01/07/1993 | CA2112226A1 Purification of recombinant apolipoprotein e from bacteria |
| 01/07/1993 | CA2111323A1 Porphycene compounds for photodynamic therapy |
| 01/05/1993 | US5177261 X-ray contrast |
| 12/30/1992 | EP0520888A1 Polyoxyethylene-polylactic acid block copolymer nanoparticles |
| 12/29/1992 | US5175380 Process for removing impurities from perfluorinated alkyl bromides or alkylene dibromides |
| 12/29/1992 | US5174987 Administering orally the contrast media consists of sodium carbonate or bicarbonate, ferrous or ferric compounds, and a neutralizing agent; easy to drink; clear and accurate contrast imaging of inner organs |
| 12/23/1992 | WO1992022586A1 Oxidized composite comprising water-soluble carboxypolysaccharide and magnetic iron oxide |
| 12/23/1992 | WO1992022583A2 Tri- and tetra-valent monospecific antigen-binding proteins |
| 12/23/1992 | WO1992022334A1 Platelet receptor antagonists useful in detecting intravascular platelet aggregation |
| 12/23/1992 | WO1992022333A1 Transgenic mice expressing human collagen gene |
| 12/23/1992 | WO1992022298A1 Novel liposomal drug delivery systems |
| 12/23/1992 | WO1992022249A1 Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes |
| 12/23/1992 | WO1992022247A1 Gas filled liposomes and their use as ultrasonic contrast agents |
| 12/23/1992 | EP0519720A1 Immunoassay of human granulocyte elastase |
| 12/23/1992 | EP0518985A1 Improvements in and relating to magnetic resonance imaging. |
| 12/23/1992 | EP0518982A1 Method for enhancing antibody transport through capillary barriers |
| 12/23/1992 | CA2110487A1 Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes |
| 12/16/1992 | EP0517854A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis |
| 12/16/1992 | EP0517788A1 19 f labelled compounds as nmr imaging and spectroscopy agents. |
| 12/16/1992 | EP0517765A1 Preparations for mr diagnosis |
| 12/16/1992 | EP0517740A1 Low molecular weight carbohydrates as additives to stabilize metal oxide compositions. |
| 12/16/1992 | CN1066977A Preparation of diagnostic agents |
| 12/15/1992 | US5171755 Containing water insoluble oil, surfactant; red blood cell substitutes, treating cardiovascular disorders |
| 12/15/1992 | US5171749 Wavelength-specific cytotoxic agents |
| 12/15/1992 | US5171741 Treating undesired biological target to destroy infected cells or viruses |
| 12/15/1992 | US5171665 Monoclonal antibody to novel antigen associated with human tumors |
| 12/15/1992 | CA1311494C Non ionic iodate triiodobenzenic compound, process for its preparation andcontrasting agent comprising it |
| 12/10/1992 | WO1992021382A1 Improvements in or relating to contrast agents |
| 12/10/1992 | WO1992021327A1 Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same |
| 12/10/1992 | WO1992018165A3 Improved fluorocarbon contrast media for use with MRI and radiographic imaging |
| 12/10/1992 | WO1992014821A3 Nestin expression as an indicator of neuroepithelial tumors |
| 12/10/1992 | CA2110590A1 Improvements in or relating to contrast agents |
| 12/09/1992 | EP0516732A1 Diagnostic aid |
| 12/09/1992 | EP0516669A1 Compositions containing green porphyrins to destroy malignant cells in mononuclear cell populations |
| 12/08/1992 | US5169944 Administering manganese mesoporphyrin, manganese deuteroporphyrin, manganese pheophorbide and manganese pyrophenophoribide |
| 12/08/1992 | US5169835 Pregancy specific proteins applications |
| 12/04/1992 | WO1992021384A1 X-ray contrast agent |
| 12/02/1992 | EP0516252A2 Monocrystalline particles of iron-oxide for application in medical diagnosis and therapy |
| 12/02/1992 | EP0516198A2 Magnetic-polymer particles |
| 12/02/1992 | EP0516135A2 Human immunodeficiency virus-related immune preparation |
| 12/02/1992 | EP0516050A2 Methods and compositions for using non-ionic contrast agents to reduce the risk of clot formation in diagnostic procedures |
| 12/02/1992 | EP0515458A1 Triarylmethyl radicals and the use of inert carbon free radicals in mri. |
| 12/02/1992 | EP0515386A1 Glycoalkaloids |
| 12/01/1992 | US5167948 Improved contrast agents for nuclear magnetic resonance imaging |
| 12/01/1992 | CA2069671A1 Human immunodeficiency virus-related immune preparation |
| 11/25/1992 | EP0514790A2 Polycondensates containing tartaric acid derivatives, process for preparation thereof and their use |
| 11/25/1992 | EP0514523A1 Method for making liposomes of enhanced entrapping capacity toward foreign substances to be encapsulated. |
| 11/25/1992 | EP0514493A1 Filter sterilization for production of colloidal, superparamagnetic mr contrast agents. |